{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:25Z","timestamp":1792276285522,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1124\/mol.119.118273","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T02:45:17Z","timestamp":1578710717000},"page":"191-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ser100-Phosphorylated ROR\u03b1 Orchestrates CAR and HNF4\u03b1 to Form Active Chromatin Complex in Response to Phenobarbital to Regulate Induction of CYP2B6"],"prefix":"10.1016","volume":"97","author":[{"given":"Muluneh","family":"Fashe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuyu","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sueyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.119.118273_bib1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jac\/dkw388","article-title":"Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children","volume":"72","author":"Bienczak","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/mol.119.118273_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1124\/jpet.108.148916","article-title":"Identification of human CYP2C8 as a retinoid-related orphan nuclear receptor target gene","volume":"329","author":"Chen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.119.118273_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/14622416.8.6.547","article-title":"Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro","volume":"8","author":"Desta","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1124\/mol.119.118273_bib4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/me.2007-0002","article-title":"The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-\/bile acid-sulfotransferase","volume":"21","author":"Echchgadda","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.119.118273_bib5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1124\/dmd.116.071076","article-title":"Evaluation of CYP2B6 induction and prediction of clinical drug-drug interactions: considerations from the IQ consortium induction working group-an industry perspective","volume":"44","author":"Fahmi","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.119.118273_bib6","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/1873-3468.13199","article-title":"Phenobarbital-induced phosphorylation converts nuclear receptor ROR\u03b1 from a repressor to an activator of the estrogen sulfotransferase gene Sult1e1 in mouse livers","volume":"592","author":"Fashe","year":"2018","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.119.118273_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/138920009787522179","article-title":"Cytochrome P450 and the biological clock in mammals","volume":"10","author":"Froy","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.119.118273_bib8","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/MCB.15.5.2517","article-title":"Determinants of target gene specificity for ROR alpha 1: monomeric DNA binding by an orphan nuclear receptor","volume":"15","author":"Gigu\u00e8re","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.119.118273_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0748730405277232","article-title":"Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors","volume":"20","author":"Guillaumond","year":"2005","journal-title":"J Biol Rhythms"},{"key":"10.1124\/mol.119.118273_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1210\/me.2016-1105","article-title":"Phosphorylation of farnesoid X receptor at serine 154 links ligand activation with degradation","volume":"30","author":"Hashiguchi","year":"2016","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.119.118273_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.apsb.2016.07.016","article-title":"Insights into CYP2B6-mediated drug-drug interactions","volume":"6","author":"Hedrich","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/mol.119.118273_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1124\/dmd.116.070235","article-title":"p38 MAP kinase links CAR activation and inactivation in the nucleus via phosphorylation at threonine 38","volume":"44","author":"Hori","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.119.118273_bib13","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1074\/jbc.M800729200","article-title":"Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene","volume":"283","author":"Inoue","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118273_bib14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.febslet.2009.05.031","article-title":"Early growth response 1 loops the CYP2B6 promoter for synergistic activation by the distal and proximal nuclear receptors CAR and HNF4alpha","volume":"583","author":"Inoue","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.119.118273_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0079-6603(01)69048-2","article-title":"The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes","volume":"69","author":"Jetten","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1124\/mol.119.118273_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1152\/physiolgenomics.00098.2007","article-title":"Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism","volume":"31","author":"Kang","year":"2007","journal-title":"Physiol Genomics"},{"key":"10.1124\/mol.119.118273_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1478-1336-2-6","article-title":"Diurnal difference in CAR mRNA expression","volume":"2","author":"Kanno","year":"2004","journal-title":"Nucl Recept"},{"key":"10.1124\/mol.119.118273_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/dmd.108.026005","article-title":"Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes","volume":"37","author":"Li","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.119.118273_bib19","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M109.048108","article-title":"Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3)","volume":"284","author":"Mutoh","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118273_bib20","doi-asserted-by":"crossref","first-page":"ra31","DOI":"10.1126\/scisignal.2003705","article-title":"Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling","volume":"6","author":"Mutoh","year":"2013","journal-title":"Sci Signal"},{"key":"10.1124\/mol.119.118273_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1124\/dmd.116.074872","article-title":"Phenobarbital meets phosphorylation of nuclear receptors","volume":"45","author":"Negishi","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.119.118273_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clpt.2006.08.013","article-title":"Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine","volume":"80","author":"Oscarson","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.119.118273_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/me.2012-1145","article-title":"Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by ROR\u03b1 and ROR\u03b3 and its potential relevance to human liver diseases","volume":"27","author":"Ou","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1124\/mol.119.118273_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAI.0b013e318183a425","article-title":"Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects","volume":"49","author":"Robertson","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1124\/mol.119.118273_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/toxsci\/kfs338","article-title":"Nuclear receptor CAR specifically activates the two-pore K+ channel Kcnk1 gene in male mouse livers, which attenuates phenobarbital-induced hepatic hyperplasia","volume":"132","author":"Saito","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/mol.119.118273_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084462","article-title":"Serine 216 phosphorylation of estrogen receptor \u03b1 in neutrophils: migration and infiltration into the mouse uterus","volume":"8","author":"Shindo","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.119.118273_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.steroids.2012.01.001","article-title":"Phosphorylation of serine 212 confers novel activity to human estrogen receptor \u03b1","volume":"77","author":"Shindo","year":"2012","journal-title":"Steroids"},{"key":"10.1124\/mol.119.118273_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1074\/jbc.M117.806604","article-title":"Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation","volume":"293","author":"Shizu","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118273_bib29","doi-asserted-by":"crossref","first-page":"e00649","DOI":"10.1128\/MCB.00649-16","article-title":"Phosphorylated nuclear receptor CAR forms a homodimer to repress its constitutive activity for ligand activation","volume":"37","author":"Shizu","year":"2017","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.119.118273_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0009-9236(03)00092-4","article-title":"Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9","volume":"74","author":"Simonsson","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.119.118273_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4155\/fmc.11.9","article-title":"The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis","volume":"3","author":"Solt","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1124\/mol.119.118273_bib32","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1074\/jbc.274.10.6043","article-title":"The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene","volume":"274","author":"Sueyoshi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118273_bib33","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41374-019-0266-1","article-title":"A phosphorylation-deficient mutant of retinoid X receptor \u03b1 at Thr 167 alters fasting response and energy metabolism in mice","volume":"99","author":"Sueyoshi","year":"2019","journal-title":"Lab Invest"},{"key":"10.1124\/mol.119.118273_bib34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1210\/me.2006-0300","article-title":"Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization","volume":"21","author":"Sun","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.119.118273_bib35","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1074\/jbc.M411318200","article-title":"Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P450 2B6 gene in HepG2 cells","volume":"280","author":"Swales","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118273_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1124\/mol.107.040741","article-title":"Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3)","volume":"73","author":"Wada","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.119.118273_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2012-06-436691","article-title":"The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1124\/mol.119.118273_bib38","doi-asserted-by":"crossref","first-page":"29295","DOI":"10.1074\/jbc.M400580200","article-title":"Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118273_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2174\/1389200033489262","article-title":"Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors","volume":"4","author":"Wang","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.119.118273_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV\/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity","volume":"306","author":"Ward","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.119.118273_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front Genet"},{"key":"10.1124\/mol.119.118273_bib42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1208\/s12248-009-9106-3","article-title":"Predicting drug-drug interactions: an FDA perspective","volume":"11","author":"Zhang","year":"2009","journal-title":"AAPS J"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.119.118273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:32:47Z","timestamp":1739961167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24009994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0026895X24009994"],"URL":"https:\/\/doi.org\/10.1124\/mol.119.118273","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ser100-Phosphorylated ROR\u03b1 Orchestrates CAR and HNF4\u03b1 to Form Active Chromatin Complex in Response to Phenobarbital to Regulate Induction of CYP2B6","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.119.118273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}